Page 34 - Ryan Jackson News Today

Researchers from Utah State University had two papers published in a major research journal earlier this month, focused on the discovery and details of a new CRISPR immune system.

Vanguard Total Market Index, Vanguard Short-Term Corporate Bond ETF, and iShares iBoxx $ Investment Grade Corporate Bond ETF among the laggards.

In this interview, News Medical speaks to Assitant Professor Ryan Jackson about his latest work, published in tandem Nature papers, detailing the discovery of a new CRISPR immune system.

How Utah State University scientists got into an academic journal with DNA discovery

Pete Tonge gives his verdict on Northwich Victorias 0-0 home draw with Wythenshawe Town...

WITTON Albions unbeaten seven-game sequence remains intact.

A pair of USU biochemists were involved in findings that describe the structure and function of a newly discovered CRISPR immune system called Cas12a2 that shuts down infected cells to stop infection in its tracks.

Scientists have described the structure and function of a newly discovered CRISPR immune system that — unlike better-known CRISPR systems that deactivate foreign genes to protect cells — shuts down infected cells to thwart infection.

In a first for the genetic toolset known as CRISPR, a recently discovered protein has been found to act as a kind of multipurpose self-destruct system for bacteria, capable of degrading single-stranded RNA, single-stranded DNA and double-stranded DNA.

In a rare feat, Utah State University biochemists Thomson Hallmark and Ryan Jackson, along with collaborators, published not one, but two seminal papers in a top-tier, peer-reviewed journal this week.